Effect of Combined Incretin-Based Therapy Plus Canagliflozin on Glycemic Control and the Compensatory Rise in Hepatic Glucose Production in Type 2 Diabetic Patients
Clinical trial NCT02324842 · COMPLETED
Trial details
- NCT number
- NCT02324842
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2018-03-28
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.